Prevalence and anti-microbial susceptibility pattern of methicillin resistant Staphylococcus aureus at a tertiary care hospital
Keywords:MRSA, Anti-microbial susceptibility, Kirby-Bauer method, Prevalence
Background: To study about the prevalence and anti-microbial susceptibility pattern of methicillin resistant Staphylococcus aureus (MRSA).
Methods: Totally 110 non-repetitive Staphylococcus aureus isolates were enrolled in this study. Isolates from different clinical specimens like pus and blood obtained from patients in tertiary care hospital and Staphylococcus aureus was identified by conventional phenotypic methods. Complete antibiotic susceptibility testing of all MRSA isolates was determined by Kirby-Bauer disc diffusion method.
Results: Out of 110 isolates of S. aureus 60 were found to be methicillin-resistant Staphylococcus aureus (MRSA). The prevalence of MRSA was 54%. Out of 60 isolates, male patients 37 (63%) and female patients are 22 (37%). Maximum numbers of isolates 25 (41.6%) were from the age group of 51 to 60 years. Among these 60 isolates, all of them were found to be resistant to penicillin and oxacillin. In contrast, 98% of the isolates were found to be sensitive to linezolid. The sensitivity to chloramphenicol 70%, co-trimoxazole 60%, amikacin 58%, clindamycin 43%, ciprofloxacin 38%, erythromycin 25%.
Conclusions: The observed prevalence rate was 54%. Linezolid showed the best therapeutic outcome against MRSA. Active screening plays an important role in control of MRSA.
Lowy FD. Staphylococcus aureus infections. New England J Med. 1998;339(8):520-32.
Rolinson NG. Celbenin - resistant Staphylococci. British Med J. 1961;1(5219):125-6.
Indian Network for Surveillance of Antimicrobial Resistance (INSAR) group, India Methicillin resistant Staphylococcus aureus (MRSA) in India: prevalence and susceptibility pattern. Indian J Med Res. 2013;137:363-9.
Drago L. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections. BMC Infectious Diseases. 2007;7(111):2334-7.
Gardam MA. Is methicillin -resistant Staphylococcus aureus an emerging community pathogen? A review of literature. Can J Infect Dis. 2000;11(4):202-11.
Kumar P, Shukla I, Varshney S. Nasal screening of healthcare workers for nasal carriage of coagulase positive MRSA and prevalence of nasal colonization with staphylococcus aureus. Biology Med. 2011;27(1):62-4.
Uma S, Santhi M. Anti-microbial susceptibility pattern of methicillin resistant staphylococcus aureus. Sri Ramachandra J Med. 1998;339:520-32.
Pai V, Rao VI, Rao SP. Prevalence and Anti-microbial Susceptibility Pattern of Methicillin-resistant Staphylococcus aureus (MRSA) Isolates at a Tertiary Care Hospital in Mangalore, South India. J Lab Physicians. 2010;2(2):82‐4.
Puneet MB, Gurpreet SB, Kundan T, Prashant J, Chaudhari CN, Naveen G, et al. Anti-microbial susceptibility profile of Methicillin-resistant Staphylococcus aureus at a Tertiary Care Centre. Archives Clin Microbiology. 2015;6(11).
Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathology. 1996;45:493-6.
Kalyani K, Karthika, Kumar J, Kumar SJ. Prevalence of Methicillin Resistant Staphylococcus Aureus Among Health Care Workers of Shri Satya Sai Medical College and Hospital: A Tertiary Care Centre. JDMS. 2012;(2):23-7.
Patel AK, Patel KK, Patel KR, Shah S, Dileep P. Time trends in the epidemiology of microbial infections at a tertiary care center in west India over last 5 years. J Assoc Physicians India. 2010;58:37-40.
Taj Y, Kazmi SU. Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance. J Coll Physicians Surg Pak. 2010;20(11):728-32.
Gopalakrishnan R, Kumar SD. Changing trends in antimicrobial susceptibility and hospital acquired infections over an 8-year period in a tertiary care hospital in relation to introduction of an infection control programme. J Assoc Physicians India. 2010;58:25-31.